The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...
Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy “In the current COVID-19 environment, the LINQ II system offers patients a seamless way to experience ...
BRAMPTON, ON-- Medtronic of Canada today announced it has received Health Canada license for the Reveal LINQ Insertable Cardiac Monitor (ICM), the smallest implantable cardiac monitoring device ...
Medtronic revealed new data Wednesday that shows a 10-fold increase in atrial fibrillation detection using the Reveal Linq insertable cardiac monitor (ICM) in stroke patients. The new data, presented ...
VALPARAISO | Porter Regional Hospital announced that it is the first hospital in northwest Indiana to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient, the ...
Medtronic recently announced that it received clearance from the FDA and CE Mark approval for its LINQ II insertable cardiac monitor (ICM). The announcement notes that ICMs “are small, subcutaneously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results